Viva Biotech Announced 2021 Annual Results: Revenue Increase

/PRNewswire/ -- On March 28, 2022, Viva Biotech Holdings (1873.HK) announced that during the year ended December 31, 2021 (the "Reporting Period"), the revenue...

Related Keywords

Chengdu , Sichuan , China , Germany , Australia , Taiwan , Japan , Shanghai , United States , United Kingdom , Jiaxing , Zhejiang , Zhoupu , Canada , France , Hangzhou , Qiantang , Guangdong , America , Cheney Mao , Technology Barriers , Viva Biotech Holdings , Absci Corporation , Viva Ai New Drug Incubation Center , Zhejiang Langhua Pharmaceutical Co Ltd , Incubation Center , Totient Inc , Financial Highlights , Reporting Period , Fierce Biotech , Mainland China , Langhua Pharmaceutical , Global Biopharmaceutical Innovation , North America , Build Technology , Faladi Road , Qiantang New District , Jiaxing Municipal Government , Drug Incubation Center , Xiuzhou District , Chief Executive Officer , Viva Biotech , Structure Based Drug Discovery ,